Telomere maintenance plays an important role in cell proliferation and tumor survival. Human male germ cells, which carry long telomeres and express telomerase, give rise to a highly heterogeneous group of malignant tumors. We compared telomeric length and telomerase activity between two major histological types of primary testicular germ cell tumors. Fifteen out of 16 seminoma samples revealed telomeric restriction fragment (TRF) length below 13 kb; the remaining seminoma showed a major TRF fraction of 18 kb and a distinct minor fraction of above 23 kb length. In contrast, all 13 samples from nonseminomas showed TRF length 523 kb, which is similar to that reported in human sperm. Nine out of 11 seminoma specimens and six out of seven nonseminomas studied showed moderate to high telomerase activity, the only telomerase-negative nonseminoma being pure mature teratoma. These results indicate to a major dierence in telomeric length between seminomas and nonseminomas, which is apparently unrelated to the presence of telomerase activity, and suggest a germline-like homeostasis of telomeric length is preserved in human nonseminomas. Oncogene (2000) 19, 4075 ± 4078.
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Keywords: testicular germ cell tumors; telomerase; telomeric length; tumor pathogenesis Cell replication-related shortening of telomeres, which may be considered as a tumor suppressor mechanism (Saretzki et al., 1999) , can be counteracted by the action of the only known eukaryotic reverse transcriptase, termed telomerase, that adds telomeric DNA repeats to chromosome termini (for review see de Lange, 1998) . There are few situations showing the use of this remedy by human cells. One is represented by germ cells, possibly the only immortal normal eukaryotic cell type, and early stage embryonic as well as fetal cells (Wright et al., 1996; Youngren et al., 1998) . Another condition is that presented by cell-renewing somatic tissues (Weng et al., 1997; Harle-Bachor et al., 1996; Yasumoto et al., 1996) . Telomerase activity may provide some compensation for high cell turnoverrelated enhanced telomeric attrition in these tissues, but it does not imply their cells are protected from senescence and, eventually, death. For instance, peripheral blood mononuclear cells show telomere erosion during both long-term culture and individual's aging despite the presence of telomerase activity (Weng et al., 1997) . Yet another scenario is realized in cells immortalized in vitro and cancer cells. The latter may carry relatively short telomeres (Bacchetti, 1996) and not necessarily be immortal (see Discussion in Hiraga et al. (1998) ). However, there is no doubt that a mechanism of telomere maintenance is required to allow the replicative lifespan of tumor cells far beyond that of their normal counterparts (Vaziri and Benchimol, 1998) . Notably, while telomeric length may vary markedly during tumor progression (Bacchetti, 1996) and telomerase expression can be activated early or late during this process, cells of a vast majority of human malignancies show telomerase activity (Shay and Bacchetti, 1997; Shay and Gazdar, 1997) . Interestingly, human germline cells, which show telomerase activity (Wright et al., 1996) and have long telomeres (Hastie et al., 1990; Allsopp et al., 1992) , give rise to less than 1% of all cancers in the general population. However, they represent a signi®cant problem, their testicular`variety' being the most common and increasingly frequent malignancy in adolescent and young adult Caucasian males (Bergstrom et al., 1996) .
There are three main types of testicular GCTs (TGCTs): seminoma, nonseminoma, and a rare spermatocytic seminoma (Mosto® and Sesterhenn, 1998) . Chromosomal constitution shows certain nonrandom dierences between seminomas and nonseminomas (Sandberg et al., 1996) . However, no structural cytogenetic change is known that would dierentiate between these two major GCT types, and their histopathogenetic relationship remains a matter of debate (Sandberg et al., 1996; Skakkebaek et al., 1998; Looijenga and Oosterhuis, 1999; Sano, 1999) . Results of our preliminary study suggested major dierences in telomeric length might exist between TGCT types (Nowak, 1997) . The goal of the present study was veri®cation of this hypothesis by telomeric length characterization of seminomas and nonseminomas. For this purpose, telomeric restriction fragment (TRF) length (an index of telomeric length) has been estimated in 31 consecutive tumor samples (excluding tumors showing high necrosis involvement, and combined' type seminomas/nonseminomas) from 29 patients with untreated primary testicular malignancies, Oncogene (2000) 19, 4075 ± 4078 ã 2000 Macmillan Publishers Ltd All rights reserved 0950 ± 9232/00 $15.00 www.nature.com/onc 20 ± 66 years of age; telomerase activity was examined in 19 of the 31. Detailed results of these analyses are given in Table 1; representative autoradiograms showing TRF length and telomerase activity are displayed in Figures 1 and 2 , respectively.
TRF length in the only two non-GCTs in our collection was less than 10 kb. Fifteen out of 16 seminoma specimens revealed peak hybridization signal between 5 and 12 kb. Two of these samples taken from distinct seminoma lesions of the same testis showed highly diering TRF length. The remaining seminoma revealed a major peak at 18 kb and a minor one at 423 kb. In contrast, all 13 specimens from nonseminomatous TGCTs (n=12) showed TRF length523 kb. The only one non-GCT examined and nine out of 11 seminoma samples showed moderate to high telomerase activity. In one seminoma specimen, telomerase activity proved inestimable because of the presence of Taq polymerase inhibitor. The remaining seminoma sample tested negative in spite of telomerase presence in another seminoma lesion of the same testis; the two specimens showed also a great disparity in their TRF lengths. Varied telomerase activity was also found in six out of seven nonseminomas, the only telomerasenegative tumor being pure mature teratoma.
The present results are consistent with our preliminary investigation (Nowak, 1997) . The only other report on telomeric length in TGCTs revealed seminoma TRF length in agreement with our data, TRF length comparable to that of normal human sperm (520 kb) in some nonseminomas, and an overall tendency (P=0.069) for higher TRF length in nonseminomas compared with that in seminomas (Albanell et al., 1999) . In our TGCT collection there was a clearcut dierence between these tumor types, with all but one seminomas showing TRF length of half or less of that in nonseminomas. The reason for this partial discrepancy may be dierent criteria of tissue quality. To minimize possible nucleic acids' degradation eect on our results, we have excluded about one third of available TGCT specimens because of marked (430%) necrosis involvement, and carefully checked all samples for 28S and/or 18S rRNA integrity. The presence of alkaline phosphatase activity which has been used as a qualifying criterion by others (Albanell et al., 1999) may be less restrictive. In brain GCTs, an average TRF length of 6.5+0.6 kb (mean+s.e.) has been reported based on analysis of only four tumors that included one or two ECs (Hiraga et al., 1998) , which suggests telomeres may be markedly shorter in brain nonseminomas than in those of the testis. Because there was no information on tissue quality in that study, one tentative explanation for this disparity might be the common presence of extensive necrosis in brain embryonal carcinoma (Kleihues et al., 1993 ). An alternative explanation would be a dissimilarity in the neoplastic pathways of GCTs in the testis and brain (Sano, 1999) .
Data on telomerase activity in human GCTs are also scarce. Except for the recent study (Albanell et al., 1999) , telomerase activity has only been reported in a few testicular tumors of unspeci®ed type (Burger , 1997) and several brain GCTs (Hiraga et al., 1998; Sano et al., 1998) . In this study, nonseminomas composed of 590% mature teratoma revealed no or low telomerase activity. This observation is consistent with the association between cell dierentiation and telomerase downregulation (Nowak and Chrapusta, 1998; Oh et al., 2000) . It is also consistent with earlier reports of no telomerase activity in mature teratomas (Albanell et al., 1999; Sano et al., 1998) and in situ hybridization studies showing the absence in testicular mature teratoma cells of human telomerase RNA subunit (hTR) that is necessary for telomerase activity (Soder et al., 1998; Delgado et al., 1999) . The present ®nding of varied telomerase activity in 90% of estimable seminoma samples is in general agreement with other reports (Hiraga et al., 1998; Albanell et al., 1999; Burger et al., 1997) . However, hTR has been found in only 62% of seminomas by in situ hybridization (Soder et al., 1998) . This dierence could be explained by the common presence in seminomas of in®ltrating lymphocytes (Mosto® and Sesterhenn, 1998) that can express telomerase (Weng et al., 1997) and give false positive results in tumor extracts. Except for the aforementioned case of mature teratoma, both the previous report (Albanell et al., 1999) and this study indicate no correlation of telomerase activity with TGCT type or patient's age. In the present study, testicular non-GCTs and all but one seminomas showed varied but markedly decreased TRF length compared to that in human sperm (Hastie et al., 1990; Allsopp et al., 1992) , which is a common ®nding in malignant tumors (Bacchetti, 1996) . In contrast, we found no similar shift in any nonseminoma examined. Moreover, there was virtually no dierence in TRF length between the TGCTs consisting exclusively of EC cells, the presumed stem cells of all nonseminomas (Lutzker and Barnard, 1998) , and either mixed-form nonseminomas containing a considerable fraction of more dierentiated cells, or tumors consisting of 590% mature teratoma cells. The dierences in telomeric length among seminomas as well as between seminomas and nonseminomas showed no apparent correlation with telomerase activity. Interestingly, long telomeres at the absence of telomerase activity were also reported in some mature teratomas by others, who postulated this speaks for telomerase repression being a late event in teratoma formation (Albanell et al., 1999) . All in all, our data suggest that germline-like homeostasis of telomeric length is preserved in nonseminomas. A consequence of this may be their somewhat lower, as compared to that of seminomas, sensitivity to chemotherapy schemes based on platinum derivatives (Oliver, 1999 ) that target, in particular, the telomeric repeats (Ishibashi and Lippard, 1998) . Notably, telomerase inhibition increases susceptibility to cisplatin of some human malignant cell lines (Kondo et al., 1998) . If nonseminomas would maintain the germlinelike homeostasis in vitro, they might provide a plausible model for studying human telomere biogenesis. An interesting model for studies on telomeric length/ telomerase regulation might also be seminomas showing no telomerase activity. It is tempting to speculate that such an apparently spontaneous switch-o in telomerase activity may underlie some of the`burned- Figure 2 Representative results of the telomeric repeat ampli®-cation protocol (TRAP). Telomerase activity was semi-quanti®ed using the original two-stage, hot start-based assay (Kim et al., 1994) . DNase-free RNase-treated extract was analysed for speci®city control. Ampli®ed products were separated on 12.5% non-denaturing polyacrylamide gels. Telomerase activity was scored +, ++ and +++, respectively, if speci®c bands could be visualized using 0.05 mg tumor extract protein and 5-h exposure, 0.005 mg protein and 5-h exposure, and 0.005 mg and 1-h exposure. The amount of protein used (mg) is shown in the uppermost line. For negative result, no speci®c product was to be found using 0.5 mg protein and 5-h exposure. Telomerase-negative extracts were examined for the presence of Taq polymerase inhibitor following supplementation with a telomerase-positive extract. Specimen numbers are shown at the bottom of the ®gure. LB=lysis buer (negative control). TSR8=positive control template Figure 1 Representative results of the TRF length analysis. High molecular weight DNA was obtained by standard methods (Sambrook et al., 1989) , taking care to minimize mixing-and transfer-related degradation. Only DNA preparations with absorbance ratio A 260 /A 280 =1.8 and no apparent fragmentation (as veri®ed by electrophoresis on 0.3% agarose) were analysed. Following digestion with HinfI and RsaI and electrophoresis on 0.8% agarose, separated DNA fragments were acid-nicked by 7-min incubation in 0.2 N HCl for ecient transfer of long DNA fragments and processed by standard Southern blotting. TRF length was estimated at the peak position of the hybridization signal instead of weighed mean approach because this results in TRF length estimates that dier by no more than one-®fth and may more accurately de®ne tumor telomeres (Engelhardt et al., 1997) . TRF length estimated by weighed mean approach is 420 kb in normal human sperm (Hastie et al., 1990) . Specimen numbers are shown in the top of the ®gure. Tumor #8 has later been found to consist of mostly necrotic choriocarcinoma and has been excluded from the study Oncogene Telomeric length in testicular germ cell tumors R Nowak et al out' tumor cases manifested by testicular scars (see Mosto® and Sesterhenn, 1998) in TGCT patients.
Telomerase activity in human tissues is under multifactorial regulation involving, in addition to hTR and telomerase catalytic subunit expression, interactions among components of the telomerase holoenzyme, including the molecular chaperons p23 and hsp 90, telomerase associated protein TEP1, and likely more (for review see Bryan and Cech, 1999) . Still an important factor in telomere maintenance must be the complex t-loop structure of the telomere itself (Grith et al., 1999) with its list of component protein`parts' presently known to telomerologists including TRF1, TRF2, tankyrase, TIN2 and Ku heterodimer (Grith et al., 1999; Kim et al., 1999; Hsu et al., 1999) . The relevance of those elaborate patterns to our ®ndings remains to be elucidated.
However, telomere/telomerase-related characteristics of immature versus mature human teratomas might complement studies on telomerase regulation during in vitro dierentiation in established cell lines. On the other hand, results of the present study may shed some light on the pathogenetic relationship between seminomas and nonseminomas of adolescents and adults. One model regarding this relationship assumes these tumors derive independently from their presumed common precursor, the carcinoma in-situ (CIS) cell (Skakkebaek et al., 1998) . The other model postulates one neoplastic pathway involving a continuous chromosome loss from CIS through seminoma to nonseminoma (Sandberg et al., 1996) . Our data speak for the ®rst model, because it does not imply losing and regaining the germ cell-like homeostasis of telomeric length.
